Feeds › Patents
Patents
New US patents granted to public companies.
About this data
- What it is
- The US Patent and Trademark Office (USPTO) grants new patents every Tuesday. We match the companies named as owners to public companies.
- Who files it
- The USPTO publishes each grant.
- How current
- Grants are published every Tuesday, and we collect them weekly.
- Worth knowing
- A patent count says little about how valuable the patents are. We match owners to companies automatically, so a few may be missed.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Patents granted per week, last 12 weeks
Latest patent grants
Showing: ticker INCY
| Granted | Patent | Owner | Type | Source |
|---|---|---|---|---|
| Oct 13, 2026 | 12760022 Tricyclic urea compounds as JAK2 V617F inhibitors | INCY Incyte Corporation | utility | Google Patents ↗ |
| Sep 29, 2026 | 12747292 Anti-tumor combination therapy comprising anti-CD19 antibody and gamm… | INCY Incyte Corporation | utility | Google Patents ↗ |
| Sep 15, 2026 | 12735424 Fused pyrazine derivatives as A2A / A2B inhibitors | INCY Incyte Corporation | utility | Google Patents ↗ |
| Aug 4, 2026 | 12698326 Anti-CD19 antibody formulations | INCY Incyte Corporation | utility | Google Patents ↗ |
| Jul 28, 2026 | 12692276 Tricyclic triazolo compounds as DGK inhibitors | INCY Incyte Corporation | utility | Google Patents ↗ |
| Jun 2, 2026 | 12643881 Bicyclic amine CDK12 inhibitors | INCY Incyte Corporation | utility | Google Patents ↗ |
| Jun 2, 2026 | 12642802 Topical formulations of ruxolitinib with an organic amine pH adjustin… | INCY Incyte Corporation | utility | Google Patents ↗ |
| May 19, 2026 | 12631639 Methods for predicting therapeutic benefit of anti-CD19 therapy in pa… | INCY Incyte Corporation | utility | Google Patents ↗ |
| May 12, 2026 | 12622908 Topical formulation for a JAK inhibitor | INCY Incyte Corporation | utility | Google Patents ↗ |
| May 12, 2026 | 12622908 Topical formulation for a JAK inhibitor | INCY Incyte Corporation | utility | Google Patents ↗ |
| Apr 14, 2026 | 12600723 Tetracyclic compounds as DGK inhibitors | INCY Incyte Corporation | utility | Google Patents ↗ |
| Apr 14, 2026 | 12600722 Tetracyclic compounds as DGK inhibitors | INCY Incyte Corporation | utility | Google Patents ↗ |
| Apr 14, 2026 | 12600717 Tricyclic compounds as inhibitors of KRAS | INCY Incyte Corporation | utility | Google Patents ↗ |
| Mar 31, 2026 | 12589096 Ruxolitinib formulation for reduction of itch in atopic dermatitis | INCY Incyte Corporation | utility | Google Patents ↗ |
| Mar 3, 2026 | 12564593 Topical formulation for a JAK inhibitor | INCY Incyte Corporation | utility | Google Patents ↗ |
| Mar 3, 2026 | 12564593 Topical formulation for a JAK inhibitor | INCY Incyte Corporation | utility | Google Patents ↗ |
| Feb 17, 2026 | 12552804 Tricyclic heterocycles as FGFR inhibitors | INCY Incyte Corporation | utility | Google Patents ↗ |
| Feb 17, 2026 | 12552792 Solid forms of an FGFR inhibitor and processes for preparing the same | INCY Incyte Corporation | utility | Google Patents ↗ |
| Feb 17, 2026 | 12551485 Topical formulations of ruxolitinib with an organic amine pH adjustin… | INCY Incyte Corporation | utility | Google Patents ↗ |
| Feb 10, 2026 | 12544381 Topical formulation for JAK inhibitor | INCY Incyte Corporation | utility | Google Patents ↗ |
| Feb 10, 2026 | 12544381 Topical formulation for JAK inhibitor | INCY Incyte Corporation | utility | Google Patents ↗ |
| Jan 27, 2026 | 12534463 Substituted tricyclic compounds as FGFR inhibitors | INCY Incyte Corporation | utility | Google Patents ↗ |
| Jan 27, 2026 | 12534463 Substituted tricyclic compounds as FGFR inhibitors | INCY Incyte Corporation | utility | Google Patents ↗ |
| Jan 6, 2026 | 12516065 Tertiary alcohols as PI3K-γ inhibitors | INCY Incyte Corporation | utility | Google Patents ↗ |
| Jan 6, 2026 | 12516059 Pyrazolopyridine compounds and uses thereof | INCY Incyte Corporation | utility | Google Patents ↗ |
| Jan 6, 2026 | 12516044 Heterocyclic compounds as immunomodulators | INCY Incyte Corporation | utility | Google Patents ↗ |
| Dec 16, 2025 | 12498382 Biomarkers for vitiligo | INCY Incyte Corporation | utility | Google Patents ↗ |
| Dec 9, 2025 | 12491244 Pharmaceutical combinations for treating tumor comprising anti-CD19 a… | INCY Incyte Corporation | utility | Google Patents ↗ |
| Nov 25, 2025 | 12479851 Process and intermediates for preparing a JAK inhibitor | INCY Incyte Corporation | utility | Google Patents ↗ |
| Nov 18, 2025 | 12473286 Salts of an FGFR inhibitor | INCY Incyte Corporation | utility | Google Patents ↗ |
| Nov 11, 2025 | 12466828 Bicyclic amines as CDK2 inhibitors | INCY Incyte Corporation | utility | Google Patents ↗ |
| Nov 11, 2025 | 12466822 Heterocyclic compounds as immunomodulators | INCY Incyte Corporation | utility | Google Patents ↗ |
| Nov 11, 2025 | 12466815 Carboxamide compounds and uses thereof | INCY Incyte Corporation | utility | Google Patents ↗ |
| Nov 4, 2025 | 12459943 Crystalline solid forms of a BET inhibitor | INCY Incyte Corporation | utility | Google Patents ↗ |
| Oct 21, 2025 | 12448448 Anti-PD-1 antibodies and uses thereof | INCY Incyte Corporation | utility | Google Patents ↗ |
| Oct 14, 2025 | 12441742 Naphthyridine compounds as inhibitors of KRAS | INCY Incyte Corporation | utility | Google Patents ↗ |
| Oct 14, 2025 | 12441731 Pyrazolopyrimidine compounds and uses thereof | INCY Incyte Corporation | utility | Google Patents ↗ |
| Oct 14, 2025 | 12441727 Tricyclic compounds as inhibitors of KRAS | INCY Incyte Corporation | utility | Google Patents ↗ |
| Oct 14, 2025 | 12440495 Combination therapy for treatment of myeloproliferative neoplasms | INCY Incyte Corporation | utility | Google Patents ↗ |
| Sep 30, 2025 | 12428426 Process and intermediates for preparing a JAK1 inhibitor | INCY Incyte Corporation | utility | Google Patents ↗ |
| Sep 30, 2025 | 12428420 Tricyclic heterocycles as FGFR inhibitors | INCY Incyte Corporation | utility | Google Patents ↗ |
| Sep 30, 2025 | 12427154 Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-b]… | INCY Incyte Corporation | utility | Google Patents ↗ |
| Sep 30, 2025 | 12427154 Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-b]… | INCY Incyte Corporation | utility | Google Patents ↗ |
| Sep 23, 2025 | 12421197 Aminopyrazine derivatives as PI3K-γ inhibitors | INCY Incyte Corporation | utility | Google Patents ↗ |
| Sep 16, 2025 | 12415809 Pyrrolotriazine compounds as tam inhibitors | INCY Incyte Corporation | utility | Google Patents ↗ |
| Sep 2, 2025 | 12404272 Process for making a PD-1/PD-L1 inhibitor and salts and crystalline f… | INCY Incyte Corporation | utility | Google Patents ↗ |
| Aug 26, 2025 | 12396993 Ruxolitinib formulation for reduction of itch in atopic dermatitis | INCY Incyte Corporation | utility | Google Patents ↗ |
| Aug 12, 2025 | 12384778 Pyrazolopyridine compounds and uses thereof | INCY Incyte Corporation | utility | Google Patents ↗ |
| Aug 12, 2025 | 12383541 ALK2 inhibitors for the treatment of anemia | INCY Incyte Corporation | utility | Google Patents ↗ |
| Aug 5, 2025 | 12378243 Quinoline compounds as inhibitors of KRAS | INCY Incyte Corporation | utility | Google Patents ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 4:59 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Clinical trial updates · FDA approvals and clearances